Literature DB >> 2998833

Cell cycle effects of iron depletion on T-47D human breast cancer cells.

R R Reddel, D W Hedley, R L Sutherland.   

Abstract

T-47D human breast cancer cells grown in culture medium containing low concentrations of fetal calf serum (FCS) proliferated very slowly, with an accumulation of cells in the G2 phase of the cell cycle, increased polyploid cells, and increased expression of transferrin receptors. Cell proliferation was stimulated by the addition of human transferrin or ammonium ferric citrate to the medium. Growth inhibition and accumulation of G2-phase cells could also be produced in T-47D cells grown in medium containing 10% FCS by the addition of the iron chelator, desferrioxamine. It is concluded that cellular deprivation of iron and/or transferrin is the major cause of reduced proliferation rates and G2-phase arrest which accompany the culture of these cells in medium supplemented with low concentrations of FCS.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998833     DOI: 10.1016/0014-4827(85)90085-0

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  6 in total

Review 1.  Regulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and Disease.

Authors:  Alexander R Bogdan; Masaki Miyazawa; Kazunori Hashimoto; Yoshiaki Tsuji
Journal:  Trends Biochem Sci       Date:  2015-12-23       Impact factor: 13.807

2.  Dietary and stored iron as predictors of breast cancer risk: A nested case-control study in Shanghai.

Authors:  Amber B Moore; Jackilen Shannon; Chu Chen; Johanna W Lampe; Roberta M Ray; Sharon K Lewis; Minggang Lin; Helge Stalsberg; David B Thomas
Journal:  Int J Cancer       Date:  2009-09-01       Impact factor: 7.396

3.  Ruthenium ammine complexes as electron acceptors for growth stimulation by plasma membrane electron transport.

Authors:  J F Laliberté; I L Sun; F L Crane; M J Clarke
Journal:  J Bioenerg Biomembr       Date:  1987-02       Impact factor: 2.945

4.  Iron alters cell survival in a mitochondria-dependent pathway in ovarian cancer cells.

Authors:  Kyle Bauckman; Edward Haller; Nicholas Taran; Stephanie Rockfield; Abigail Ruiz-Rivera; Meera Nanjundan
Journal:  Biochem J       Date:  2015-03-01       Impact factor: 3.857

Review 5.  Iron deprivation in cancer--potential therapeutic implications.

Authors:  Jessica L Heath; Joshua M Weiss; Catherine P Lavau; Daniel S Wechsler
Journal:  Nutrients       Date:  2013-07-24       Impact factor: 5.717

6.  The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells.

Authors:  Michela Asperti; Luca Cantamessa; Simone Ghidinelli; Magdalena Gryzik; Andrea Denardo; Arianna Giacomini; Giovanna Longhi; Alessandro Fanzani; Paolo Arosio; Maura Poli
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.